Expert Opinion on Therapeutic Targets

Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades
pp. 1337-1346(10)
Authors: Lunin, Sergey M.; Glushkova, Olga V.; Khrenov, Maxim O.; Parfenyuk, Svetlana B.; Novoselova, Tatyana V.; Fesenko, Evgeny E.; Novoselova, Elena G.

Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction
pp. 1347-1353(7)
Authors: Tsioufis, Costas; Aggelis, Athanasios; Dimitriadis, Kyriakos; Thomopoulos, Costas; Kasiakogias, Alexandros; Tzamou, Vanessa; Kyvelou, Stella-Maria; Mikhailidis, Dimitri P.; Papademetriou, Vasilios; Stefanadis, Christodoulos

Are we moving in the right direction with osteoarthritis drug discovery?
pp. 1355-1368(14)
Author: Bondeson, Jan

Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
pp. 1369-1386(18)
Authors: Henkin, Jack; Volpert, Olga V

Convergent mechanisms in etiologically-diverse dystonias
pp. 1387-1403(17)
Authors: Thompson, Valerie B; Jinnah, H A; Hess, Ellen J

Advances in the design and synthesis of prazosin derivatives over the last ten years
pp. 1405-1418(14)
Authors: Desiniotis, Andreas; Kyprianou, Natasha

Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer
pp. 1419-1422(4)
Author: Doggrell, Sheila A

Ketamine may exert antidepressant effects via mediating the kynurenine pathway
pp. 1423-1424(2)
Authors: Yang, Chun; Zhou, Zhiqiang; Shi, Jinyun; Yang, Jianjun